Mike Rogers

Mike Rogers is a distinguished professional with extensive expertise in Biochemistry and Bone Pharmacology.

He graduated with a first-class honors in Biochemistry from the University of Sheffield in 1989, followed by a PhD in Bone Pharmacology in 1994.

Mike's career progressed as a postdoctoral fellow and lecturer at the University of Sheffield, transitioning to the role of Senior Lecturer at the University of Aberdeen in 1999 and eventually becoming a Professor of Musculoskeletal Pharmacology in 2003.

He played a pivotal role in leading the Musculoskeletal Research Programme at the University of Aberdeen from 2005 to 2010, solidifying its reputation as a Center of Excellence in bone research acknowledged by the European League Against Rheumatism.

With profound connections in the pharmaceutical industry, Mike has served on various Editorial Boards and Grant and Fellowship Committees, demonstrating his commitment to advancing the field of pharmacology.

He also held positions on the Board of Directors of the International Bone & Mineral Society and the committee of the UK Bone Research Society, showcasing his leadership in bone-related organizations.

In 2012, Mike transitioned to the Garvan Institute, focusing on establishing a pioneering Bone Therapeutics Group within the Division of Bone Biology.

His seminal work on bisphosphonates, a widely-used class of drugs for bone diseases, has been instrumental in understanding their mechanisms of action and adverse effects.

Mike's current research interests encompass immune regulation of bone metastasis, pharmacological interventions for bone diseases, and the molecular basis of autoinflammatory diseases linked to cholesterol metabolism defects.

His profound contributions to bone cell biology and human bone diseases underscore his profound impact on the field of pharmacology.

As a Professor at the Garvan Institute of Medical Research and having previously held the position of Professor of Musculoskeletal Pharmacology at the University of Aberdeen, Mike Rogers continues to be a respected authority in the field of bone research and pharmacology.